Cencora Inc. stock outperforms competitors despite losses on the day
Cencora Inc. closed 7.12% below its 52-week high of $262.26, which the company reached on February 5th.
centerforbiosimilars48m
Psoriasis Biosimilars Saved VA $67 Million in 2023
The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...